Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients

INTRODUCTION: Blood product transfusion retains a critical role in the supportive care of patients with acute myeloid leukemia (AML). Whereas previous studies have shown increased transfusion dependency to portend inferior outcome, predictive factors of an increased transfusion burden and the progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Liron, Freed-Freundlich, Mor, Shimoni, Avichai, Hellou, Tamer, Avigdor, Abraham, Misgav, Mudi, Canaani, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601600/
https://www.ncbi.nlm.nih.gov/pubmed/37899992
http://dx.doi.org/10.1159/000529595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601600/
https://www.ncbi.nlm.nih.gov/pubmed/37899992
http://dx.doi.org/10.1159/000529595

Ejemplares similares